Understanding the gold price rollercoaster

ON GOLD

clock

Boosted by central bank largesse and negative real rates of the key reserve currencies, global markets continue their inexorable rise to new highs. Bulls argue that valuations for international large caps are low by historical standards, balance sheets are strong and dividend yields are attractive.

The bears point to the disconnect between equity valuations and the state of the global economy; France is in a recession, Italy has been contracting for seven consecutive quarters and Germany just narrowly avoided a technical recession with first quarter GDP growth of only 0.1%. Even though the US shows some nascent signs of strength, the contrast in investor outlook towards North America and Europe reminds me of the ‘the greater fool game’ – keep buying something that goes up in the hope that some other fool will pay more for it. As the equity bulls appear to be winning, traditional...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot